Oncology news

Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women [1], led in the UK by Queen Mary University of London.

Public awareness of urological conditions is alarmingly low throughout Europe. Results of a new international survey [1] of more than 2,500 responders from 5 countries show that women know more about men’s health issues than men do, men have poor knowledge of key urological symptoms and don’t take early signs of potentially life-threatening urological conditions seriously.

As in most developed European countries, a vaccination programme against HPV has also been introduced in the Czech Republic. HPV vaccines are reimbursed from the public health insurance if the first dose is administered between ages 13 and 14. Both girls and boys can be vaccinated under this scheme.

New evidence published in the Cochrane Library [1] shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarises findings on harms that have been assessed in randomised controlled trials.

Colorectal cancer is the third most common cancer in men and the second most common in women and represents almost 10% of the annual global cancer incidence. Yet the disease is preventable with a healthy lifestyle and efficient screening. The International Agency for Research on Cancer (IARC) Handbooks of Cancer Prevention programme has evaluated the effectiveness of various colorectal cancer screening methods.